Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > Scotland > 4D PHARMA RESEARCH LIMITED
Company Information for

4D PHARMA RESEARCH LIMITED

C/O INTERPATH LIMITED 5TH FLOOR, 130 ST. VINCENT STREET, GLASGOW, G2 5HF,
Company Registration Number
SC336222
Private Limited Company
In Administration

Company Overview

About 4d Pharma Research Ltd
4D PHARMA RESEARCH LIMITED was founded on 2008-01-15 and has its registered office in Glasgow. The organisation's status is listed as "In Administration". 4d Pharma Research Limited is a Private Limited Company registered in with Companies House and the accounts submission requirement is categorised as FULL
  • Annual turnover is £6.5 million or more
  • The balance sheet total is £ 3.26 million or more
  • Employs 50 or more employees
  • May be publically listed
  • May be a member of a group of companies meeting any of the above criteria
Key Data
Company Name
4D PHARMA RESEARCH LIMITED
 
Legal Registered Office
C/O INTERPATH LIMITED 5TH FLOOR
130 ST. VINCENT STREET
GLASGOW
G2 5HF
Other companies in AB25
 
Previous Names
GT BIOLOGICS LIMITED30/03/2015
MM&S (5335) LIMITED14/03/2008
Filing Information
Company Number SC336222
Company ID Number SC336222
Date formed 2008-01-15
Country 
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus In Administration
Lastest accounts 31/12/2021
Account next due 30/09/2023
Latest return 15/01/2016
Return next due 12/02/2017
Type of accounts FULL
VAT Number /Sales tax ID GB936837873  
Last Datalog update: 2023-06-05 18:54:16
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for 4D PHARMA RESEARCH LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of 4D PHARMA RESEARCH LIMITED

Current Directors
Officer Role Date Appointed
LAURENCE SMITH DALE
Company Secretary 2012-11-20
DUNCAN JOSEPH PEYTON
Director 2012-11-12
ALEXANDER JAMES STEVENSON
Director 2013-09-11
Previous Officers
Officer Role Date Appointed Date Resigned
DOUGLAS CAMPBELL THOMSON
Director 2013-09-11 2015-12-31
THOMAS ENGELEN
Director 2012-11-12 2015-04-30
DENISE KELLY
Director 2008-03-12 2013-10-04
KEITH DAVID ROY WINTON
Company Secretary 2008-03-12 2012-11-12
HOWARD JOHN MARRIGE
Director 2008-03-12 2012-09-04
MACLAY MURRAY & SPENS LLP
Nominated Secretary 2008-01-15 2008-03-12
VINDEX LIMITED
Nominated Director 2008-01-15 2008-03-12
VINDEX SERVICES LIMITED
Nominated Director 2008-01-15 2008-03-12

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
DUNCAN JOSEPH PEYTON THE MICROBIOTA COMPANY LIMITED Director 2014-07-17 CURRENT 2014-07-15 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON MICROBIOMICS LIMITED Director 2014-04-01 CURRENT 2014-01-31 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON 4D PHARMA PLC Director 2014-01-18 CURRENT 2014-01-10 In Administration
DUNCAN JOSEPH PEYTON SCHOSWEEN 18 LIMITED Director 2013-11-28 CURRENT 2013-11-28 Dissolved 2017-09-19
DUNCAN JOSEPH PEYTON AQUARIUS PHARMA LIMITED Director 2013-06-24 CURRENT 2013-06-24 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS LIFE SCIENCE LIMITED Director 2012-11-07 CURRENT 2012-11-07 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS IV FUND MANAGING MEMBER LIMITED Director 2010-10-05 CURRENT 2010-02-24 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS ORIGIN FUND MANAGING MEMBER LIMITED Director 2009-04-03 CURRENT 2009-03-02 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON NORTH WEST SEED FUND GENERAL PARTNER LIMITED Director 2009-01-28 CURRENT 2003-08-18 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON NORTH WEST SEED FUND FOUNDER PARTNER LIMITED Director 2009-01-28 CURRENT 2003-08-18 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS NORTHERN ENTREPRENEURS MANAGING MEMBER LIMITED Director 2006-07-25 CURRENT 2006-07-25 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS EQUITY HOLDINGS LIMITED Director 2005-07-12 CURRENT 2005-02-07 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS EQUITY DIRECTOR LIMITED Director 2004-09-01 CURRENT 2004-07-02 Active - Proposal to Strike off
DUNCAN JOSEPH PEYTON AQUARIUS EQUITY PARTNERS LIMITED Director 2004-08-19 CURRENT 2002-06-26 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON C4X DISCOVERY HOLDINGS PLC Director 2014-09-03 CURRENT 2014-07-16 Active
ALEXANDER JAMES STEVENSON AQUARIUS EQUITY DIRECTOR LIMITED Director 2014-08-20 CURRENT 2004-07-02 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON AQUARIUS IV FUND MANAGING MEMBER LIMITED Director 2014-08-20 CURRENT 2010-02-24 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON AQUARIUS ORIGIN FUND MANAGING MEMBER LIMITED Director 2014-08-20 CURRENT 2009-03-02 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON THE MICROBIOTA COMPANY LIMITED Director 2014-07-17 CURRENT 2014-07-15 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON AQUARIUS LIFE SCIENCE LIMITED Director 2014-05-28 CURRENT 2012-11-07 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON MICROBIOMICS LIMITED Director 2014-04-01 CURRENT 2014-01-31 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON 4D PHARMA PLC Director 2014-01-18 CURRENT 2014-01-10 In Administration
ALEXANDER JAMES STEVENSON NORTH WEST SEED FUND GENERAL PARTNER LIMITED Director 2013-12-19 CURRENT 2003-08-18 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON SCHOSWEEN 18 LIMITED Director 2013-11-28 CURRENT 2013-11-28 Dissolved 2017-09-19
ALEXANDER JAMES STEVENSON AQUARIUS NORTHERN ENTREPRENEURS MANAGING MEMBER LIMITED Director 2013-07-23 CURRENT 2006-07-25 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON AQUARIUS EQUITY PARTNERS LIMITED Director 2008-05-02 CURRENT 2002-06-26 Active - Proposal to Strike off
ALEXANDER JAMES STEVENSON AQUARIUS EQUITY HOLDINGS LIMITED Director 2008-05-02 CURRENT 2005-02-07 Active - Proposal to Strike off

More director information

Advertised Job Vacancies
Job TitleLocationJob descriptionDate posted
Preclinical Research Assistant / ScientistAberdeen City*Job Description- Preclinical Models Research Assistant / Scientist* *About the Company* 4D Pharma PLC is a pharmaceutical company focussed on developing2016-11-21
Senior MicrobiologistAberdeen CityApplications are invited for the role of Senior Microbiologist to join the research team at 4D Pharma Research Ltd in Aberdeen (UK)....2016-11-17
Division Head (II)Aberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Job Description- Division Head (Discovery II)*....2016-11-17
Division Head (I)Aberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Job Description- Division Head (Discovery I)*....2016-11-17
Research Technician in Molecular MicrobiologyAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. About the Company*....2016-11-10
Clinical Trial Administrator (CTA)Aberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Clinical Trial Administrator (CTA)*....2016-09-23
Senior Administrator/HR ManagerAberdeen CityApplications are invited for an exciting new Senior Administrator/HR Manager position at 4D Pharma plc. 4D Pharma is a pharmaceutical company focussed on2016-04-12
ImmunologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-03-09
Cell Biologist/PhysiologistAberdeen CityApplications are invited for an exciting new research position at 4D Pharma Research Ltd in Aberdeen (UK). 4D Pharma PLC is a pharmaceutical company focussed on...2016-03-09
Molecular MicrobiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-03-09
Microbiologist IsolationAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-03-09
Industrial MicrobiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-03-09
Laboratory TechnicianAberdeen CityApplications are invited for a new position of Laboratory Technician in the Research group of 4D Pharma (Aberdeen). The post holder will be an integral part of2016-03-09
Clinical MicrobiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-03-09
Laboratory TechnicianAberdeen CityApplications are invited for a new position of Laboratory Technician in the Research group of 4D Pharma (Aberdeen). The post holder will be an integral part of2016-02-08
Microbiology Fermentation TechnicianAberdeen CityThis will involve the daily operation of fermentation equipment, media preparation, and laboratory maintenance....2016-01-06
Molecular MicrobiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-01-05
ImmunologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-01-05
Cell Biologist/PhysiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-01-05
Microbiologist IsolationAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-01-05
Industrial MicrobiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-01-05
Clinical MicrobiologistAberdeen City4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome....2016-01-05
Microbiology Research Assistant/ScientistAberdeen CityThe candidate will lead the development of innovative microbial characterisation technologies to drive forward the proprietary MicroRx discovery platform....2015-11-18

Jobs results powered by Indeed
Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-02-22Error
2023-05-18Error
2023-04-27Error
2023-04-12Error
2023-04-05REGISTERED OFFICE CHANGED ON 05/04/23 FROM Life Science Innovation Building Cornhill Road Aberdeen AB25 2ZS
2023-04-03APPOINTMENT TERMINATED, DIRECTOR ALEXANDER JAMES STEVENSON
2023-04-03APPOINTMENT TERMINATED, DIRECTOR ALEXANDER JAMES STEVENSON
2023-04-03Termination of appointment of Duncan Peyton on 2023-03-16
2023-04-03APPOINTMENT TERMINATED, DIRECTOR DUNCAN JOSEPH PEYTON
2023-04-03APPOINTMENT TERMINATED, DIRECTOR DUNCAN JOSEPH PEYTON
2023-03-21Error
2023-03-21Error
2023-01-18CONFIRMATION STATEMENT MADE ON 07/01/23, WITH NO UPDATES
2022-07-29MR01REGISTRATION OF A CHARGE / CHARGE CODE SC3362220005
2022-07-13AAFULL ACCOUNTS MADE UP TO 31/12/21
2022-01-18CONFIRMATION STATEMENT MADE ON 07/01/22, WITH NO UPDATES
2022-01-18CS01CONFIRMATION STATEMENT MADE ON 07/01/22, WITH NO UPDATES
2021-08-11MR01REGISTRATION OF A CHARGE / CHARGE CODE SC3362220003
2021-08-10MEM/ARTSARTICLES OF ASSOCIATION
2021-08-10RES13Resolutions passed:
  • Approval of certain documents 28/07/2021
  • ADOPT ARTICLES
2021-08-05MR01REGISTRATION OF A CHARGE / CHARGE CODE SC3362220002
2021-06-11AAFULL ACCOUNTS MADE UP TO 31/12/20
2021-01-10CS01CONFIRMATION STATEMENT MADE ON 07/01/21, WITH NO UPDATES
2020-07-17AAFULL ACCOUNTS MADE UP TO 31/12/19
2020-02-07CS01CONFIRMATION STATEMENT MADE ON 07/01/20, WITH NO UPDATES
2020-02-06TM02Termination of appointment of Laurence Smith Dale on 2020-01-31
2020-02-06AP03Appointment of Mr Duncan Peyton as company secretary on 2020-01-31
2019-06-06AAFULL ACCOUNTS MADE UP TO 31/12/18
2019-01-07CS01CONFIRMATION STATEMENT MADE ON 07/01/19, WITH NO UPDATES
2018-05-09AAFULL ACCOUNTS MADE UP TO 31/12/17
2018-03-21LATEST SOC21/03/18 STATEMENT OF CAPITAL;GBP 1087.64
2018-03-21CS01CONFIRMATION STATEMENT MADE ON 21/03/18, WITH UPDATES
2018-01-16SH10Particulars of variation of rights attached to shares
2018-01-16SH08Change of share class name or designation
2018-01-16RES12Resolution of varying share rights or name
2018-01-16RES01ADOPT ARTICLES 31/12/2017
2018-01-08CS01CONFIRMATION STATEMENT MADE ON 30/12/17, WITH NO UPDATES
2017-09-01PSC05Change of details for 4D Pharma Plc as a person with significant control on 2017-09-01
2017-09-01CH01DIRECTOR'S CHANGE OF PARTICULARS / MR ALEXANDER JAMES STEVENSON / 01/09/2017
2017-09-01CH01DIRECTOR'S CHANGE OF PARTICULARS / MR DUNCAN JOSEPH PEYTON / 01/09/2017
2017-09-01CH03SECRETARY'S DETAILS CHNAGED FOR LAURENCE SMITH DALE on 2017-09-01
2017-06-09AAFULL ACCOUNTS MADE UP TO 31/12/16
2017-01-06LATEST SOC06/01/17 STATEMENT OF CAPITAL;GBP 1087.64
2017-01-06CS01CONFIRMATION STATEMENT MADE ON 06/01/17, WITH UPDATES
2016-09-07AAFULL ACCOUNTS MADE UP TO 31/12/15
2016-01-22CH01DIRECTOR'S CHANGE OF PARTICULARS / MR ALEXANDER JAMES STEVENSON / 21/01/2016
2016-01-22CH01DIRECTOR'S CHANGE OF PARTICULARS / MR DUNCAN JOSEPH PEYTON / 21/01/2016
2016-01-22CH03SECRETARY'S DETAILS CHNAGED FOR LAURENCE SMITH DALE on 2016-01-21
2016-01-22LATEST SOC22/01/16 STATEMENT OF CAPITAL;GBP 1087.64
2016-01-22AR0115/01/16 ANNUAL RETURN FULL LIST
2016-01-06TM01APPOINTMENT TERMINATED, DIRECTOR DOUGLAS CAMPBELL THOMSON
2015-08-05AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-06-03TM01APPOINTMENT TERMINATED, DIRECTOR THOMAS ENGELEN
2015-04-20CH01Director's details changed for Mr Duncan Joseph Peyton on 2015-03-25
2015-04-07MISCSect 519 auditor's letter
2015-03-30RES15CHANGE OF NAME 30/03/2015
2015-03-30CERTNMCompany name changed gt biologics LIMITED\certificate issued on 30/03/15
2015-02-10LATEST SOC10/02/15 STATEMENT OF CAPITAL;GBP 1087.64
2015-02-10AR0115/01/15 FULL LIST
2015-02-09SH0112/11/12 STATEMENT OF CAPITAL GBP 1087.64
2014-10-13AA31/12/13 TOTAL EXEMPTION SMALL
2014-06-06MEM/ARTSARTICLES OF ASSOCIATION
2014-06-06RES01ALTER ARTICLES 03/06/2014
2014-06-06SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2014-06-06SH10NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES
2014-03-06RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2014-01-31LATEST SOC31/01/14 STATEMENT OF CAPITAL;GBP 1023.92
2014-01-31AR0115/01/14 FULL LIST
2014-01-03SH0104/12/13 STATEMENT OF CAPITAL GBP 1023.92
2013-10-21AA31/12/12 TOTAL EXEMPTION SMALL
2013-10-04TM01APPOINTMENT TERMINATED, DIRECTOR DENISE KELLY
2013-09-20AP01DIRECTOR APPOINTED MR DOUGLAS CAMPBELL THOMSON
2013-09-20AP01DIRECTOR APPOINTED ALEX STEVENSON
2013-07-24AD01REGISTERED OFFICE CHANGED ON 24/07/2013 FROM ROOM W05 LIFE SCIENCE INNOVATION BUILDING CORNHILL ROAD ABERDEEN AB25 2ZS SCOTLAND
2013-07-08SH0128/06/13 STATEMENT OF CAPITAL GBP 523.92
2013-06-28AD01REGISTERED OFFICE CHANGED ON 28/06/2013 FROM C/O C/O PROFESSOR DENISE KELLY ROOM 3.17 INSTITUTE OF MEDICAL SCIENCES FORESTERHILL ABERDEEN AB25 2ZD UNITED KINGDOM
2013-02-11AR0115/01/13 FULL LIST
2012-11-29AP01DIRECTOR APPOINTED THOMAS ENGELEN
2012-11-28AP03SECRETARY APPOINTED LAURENCE SMITH DALE
2012-11-28AP01DIRECTOR APPOINTED MR DUNCAN JOSEPH PEYTON
2012-11-28TM02APPOINTMENT TERMINATED, SECRETARY KEITH WINTON
2012-11-28AD01REGISTERED OFFICE CHANGED ON 28/11/2012 FROM C/O THOERIS CONSULTANTS LTD 6 GREENBANK ROW EDINBURGH EH10 5SY SCOTLAND
2012-11-28SH0112/11/12 STATEMENT OF CAPITAL GBP 440.59
2012-11-26CC04STATEMENT OF COMPANY'S OBJECTS
2012-11-26RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2012-11-26RES13REMOVAL OF CURRENT AUTH SHARE CAPITAL, CREATION OF NEW A ORD SHARES 08/11/2012
2012-11-26SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2012-09-10TM01APPOINTMENT TERMINATED, DIRECTOR HOWARD MARRIGE
2012-04-10AA31/12/11 TOTAL EXEMPTION SMALL
2012-01-26AR0115/01/12 FULL LIST
2011-06-15AA31/12/10 TOTAL EXEMPTION SMALL
2011-01-20AR0115/01/11 FULL LIST
2011-01-05AD01REGISTERED OFFICE CHANGED ON 05/01/2011 FROM WALLACE BUILDING ROSLIN BIOCENTRE ROSLIN EH25 9PP
2010-11-08SH0131/10/10 STATEMENT OF CAPITAL GBP 290.59
2010-09-08AA31/12/09 TOTAL EXEMPTION SMALL
2010-01-25AR0115/01/10 FULL LIST
2010-01-25CH01DIRECTOR'S CHANGE OF PARTICULARS / DR HOWARD JOHN MARRIGE / 15/01/2010
2010-01-25CH01DIRECTOR'S CHANGE OF PARTICULARS / DENISE KELLY / 15/01/2010
2009-12-02SH0127/11/09 STATEMENT OF CAPITAL GBP 133.78
2009-10-09AA31/12/08 TOTAL EXEMPTION SMALL
2009-01-23363aRETURN MADE UP TO 15/01/09; FULL LIST OF MEMBERS
2008-04-04288aDIRECTOR APPOINTED DR HOWARD JOHN MIRRAGE
2008-04-01225ACC. REF. DATE SHORTENED FROM 31/01/2009 TO 31/12/2008
2008-04-01287REGISTERED OFFICE CHANGED ON 01/04/2008 FROM QUARTERMILE ONE 15 LAURISTON PLACE EDINBURGH EH3 9EP
2008-04-01123NC INC ALREADY ADJUSTED 12/03/08
2008-04-01288bAPPOINTMENT TERMINATED SECRETARY MACLAY MURRAY & SPENS LLP
2008-04-01288aDIRECTOR APPOINTED DENISE KELLY
2008-04-01288bAPPOINTMENT TERMINATED DIRECTOR VINDEX SERVICES LIMITED
2008-04-01288bAPPOINTMENT TERMINATED DIRECTOR VINDEX LIMITED
2008-04-0188(2)AD 12/03/08 GBP SI 10400@0.01=104 GBP IC 2/106
2008-03-25288aSECRETARY APPOINTED DR KEITH DAVID ROY WINTON
2008-03-25122S-DIV
2008-03-17RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2008-03-17RES01ADOPT ARTICLES 12/03/2008
2008-03-14CERTNMCOMPANY NAME CHANGED MM&S (5335) LIMITED CERTIFICATE ISSUED ON 14/03/08
2008-01-15NEWINCINCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to 4D PHARMA RESEARCH LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
Appointmen2023-03-21
Fines / Sanctions
No fines or sanctions have been issued against 4D PHARMA RESEARCH LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 5
Mortgages/Charges outstanding 5
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
We do not yet have the details of 4D PHARMA RESEARCH LIMITED's previous or outstanding mortgage charges.
Filed Financial Reports
Annual Accounts
2014-12-31
Annual Accounts
2013-12-31
Annual Accounts
2012-12-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on 4D PHARMA RESEARCH LIMITED

Intangible Assets
Patents
We have not found any records of 4D PHARMA RESEARCH LIMITED registering or being granted any patents
Domain Names

4D PHARMA RESEARCH LIMITED owns 4 domain names.

gt-therapeutics.co.uk   gtprohealth.co.uk   gttherapeutics.co.uk   gt-prohealth.co.uk  

Trademarks

Trademark applications by 4D PHARMA RESEARCH LIMITED

4D PHARMA RESEARCH LIMITED is the Original registrant for the trademark 4D ™ (88122086) through the USPTO on the 2018-09-18
Prescribed pharmaceuticals as live biotherapeutics for the treatment of cancer, central nervous system diseases, and gastrointestinal diseases; live biotherapeutic pharmaceuticals for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; lyophilized formulations of microorganisms for medical use
Income
Government Income
We have not found government income sources for 4D PHARMA RESEARCH LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as 4D PHARMA RESEARCH LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where 4D PHARMA RESEARCH LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Legal Notices/Action
Initiating party Event TypeAppointmen
Defending party4D PHARMA RESEARCH LIMITEDEvent Date2023-03-21
In the Court of Session No P234 of 23. 4D PHARMA RESEARCH LIMITED Company Number: SC336222 Previous Name of Company: GT BIOLOGICS LIMITED, MM&S (5335) LIMITED Nature of Business: Research and experime…
 
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded 4D PHARMA RESEARCH LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded 4D PHARMA RESEARCH LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.